✦ LIBER ✦

PCN59 REAL-WORLD COSTS OF ADJUVANT TREATMENT FOR STAGE III COLON CANCER PATIENTS IN THE NETHERLANDS

✍ Scribed by CWM van Gils; SS Tan; WK Redekop; CJA Punt

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN22 IS CAPECITABINE A COST-EFFECTIVE A

✍ MC Orchard; J Hoch; SMH Alibhai 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

4009 POSTER Less Adjuvant Chemotherapy f

✍ van Steenbergen, L.N.; Lemmens, V.E.P.R.; Rutten, H.J.T.; Wymenga, A.N.M.; Norti 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB

PCN80 COST-EFFECTIVENESS ANALYSIS OF OXL

✍ T Fukuda; T Shiroiwa; T Takeuchi; K Shimozuma; Y Ohashi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PCN106 Capecitabine Plus Oxaliplatin (CA

✍ van Gils, C.W.M.; de Groot, S.; Redekop, W.K.; Uyl-De Groot, C.A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PCN191 Economic Evaluation of XELOX vs F

✍ Kim, C.M.; Ju, S.Y.; Kim, S.H.; Kang, M.; Park, J.; Choi, W.S. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCN13 COST-EFFECTIVENESS OF ADJUVANT CAP

✍ P Tilleul; G Perrocheau; A Lafuma; E Roux 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB